Stock Events

Stock Events

Tiziana Life Sciences

€1.19

41

+€0.02+1.71% Tuesday 19:56

Statistics

Day High

1.21

Day Low

1.15

52W High

2.06

52W Low

0.96

Volume

-

Avg. Volume

-

Mkt Cap

0

P/E Ratio

-

Dividend Yield

-

Dividend

-

Upcoming

Earnings

18JunExpected

Q3 2025

Next

Next

-0.09

-0.08

-0.07

-0.06

Expected EPS

-0.09368739229907201

Actual EPS

N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 0RP.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Bristol-Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company focusing on discovering, developing, and delivering innovative medicines for patients with serious diseases, including areas where Tiziana is active.

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals is involved in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions, competing directly in the biotech space with Tiziana.

Gilead Sciences

Gilead Sciences is a biopharmaceutical company that researches, develops, and commercializes drugs in areas overlapping with Tiziana's interests, particularly in oncology and inflammatory diseases.

Amgen is a biotechnology pioneer that discovers, develops, manufactures, and delivers innovative human therapeutics, including treatments in areas that Tiziana Life Sciences targets.

AbbVie is a research-based biopharmaceutical company with a strong emphasis on research and development in areas similar to Tiziana, such as immunology and oncology.

Merck & Co., Inc. is a global healthcare company that operates in the same therapeutic areas as Tiziana, making it a direct competitor in the pharmaceutical and biotech industry.

Pfizer is a global pharmaceutical corporation with a broad range of products in various therapeutic areas, including those being pursued by Tiziana, making it a competitor.

Novartis is a global healthcare company that engages in the research, development, manufacturing, and marketing of a wide range of healthcare products, directly competing with Tiziana.

Roche Holding AG is a leader in research-focused healthcare with strengths in pharmaceuticals and diagnostics, competing in the same therapeutic areas as Tiziana.

AstraZeneca is a global, science-led biopharmaceutical business that focuses on the discovery, development, and commercialization of prescription medicines, including in areas that overlap with Tiziana's focus.

About

Tiziana Life Sciences Ltd, a biotechnology company, engages in the development of transformative therapies for neurodegenerative and lung diseases in the United States. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for use in the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases. It is also developing TZLS-501, a fully human mAb targeting the IL-6 receptor for use in the treatment of inflammatory and oncology indications. Tiziana Life Sciences Ltd was incorporated in 1998 and is headquartered in London, the United Kingdom.

Show more...

CEO

Mr. Gabriele Marco Antonio Cerrone M.B.A.

Employees

9

Country

United Kingdom

ISIN

BMG889121031

Listings

0 Comments

Share your thoughts

FAQ

What is Tiziana Life Sciences stock price today?▼

The current price of 0RP.STU is €1.19 EUR — it has increased by +1.71% in the past 24 hours. Watch Tiziana Life Sciences stock price performance more closely on the chart.

What is Tiziana Life Sciences stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange Tiziana Life Sciences stocks are traded under the ticker 0RP.STU.

Is Tiziana Life Sciences stock price growing?▼

0RP.STU stock has risen by +12.26% compared to the previous week, the month change is a +13.33% rise, over the last year Tiziana Life Sciences has showed a +12.26% increase.

When is the next Tiziana Life Sciences earnings date?▼

Tiziana Life Sciences is going to release the next earnings report on June 18, 2026.

How many employees does Tiziana Life Sciences have?▼

As of May 06, 2026, the company has 9 employees.

In which sector is Tiziana Life Sciences located?▼

Tiziana Life Sciences operates in the Health & Wellness sector.

When did Tiziana Life Sciences complete a stock split?▼

Tiziana Life Sciences has not had any recent stock splits.

Where is Tiziana Life Sciences headquartered?▼

Tiziana Life Sciences is headquartered in London, United Kingdom.